Back to search
FDAFDA · Food and drugs·Recall number D-0672-2016

Rhino 7 3000, 6 count Bottle, Distributed by Rhino 7, Made in USA

Published February 24, 2016 · Recall initiated: September 30, 2015

Summary

FDA records drug Class I recall D-0672-2016, published February 24, 2016 and initiated September 30, 2015. Recalling firm: Premiere Sales Group; Status: Terminated; Reported quantity: 337 bottles; Lot: All lots. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed without an Approved NDA/ANDA: Products contain undeclared active pharmaceutical ingredients; desmethyl carbondenafil and dapoxetine.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Premiere Sales Group
Distributor
Nationwide
Lot
All lots
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Rhino 7 3000, 6 count Bottle, Distributed by Rhino 7, Made in USA recalled?

Yes. FDA published recall D-0672-2016 on February 24, 2016. Reported hazard: Marketed without an Approved NDA/ANDA: Products contain undeclared active pharmaceutical ingredients; desmethyl carbondenafil and dapoxetine.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail